Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
J Neurosurg ; 106(3): 391-9, 2007 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-17367061

RESUMEN

OBJECT: The authors present the long-term results of nerve grafting and neurotization procedures in their group of patients with brachial plexus injuries and compare the results of "classic" methods of nerve repair with those of end-to-side neurorrhaphy. METHODS: Between 1994 and 2006, direct repair (nerve grafting), neurotization, and end-to-side neurorrhaphy were performed in 168 patients, 95 of whom were followed up for at least 2 years after surgery. Successful results were achieved in 79% of cases after direct repair and in 56% of cases after end-to-end neurotization. The results of neurotization depended on the type of the donor nerve used. In patients who underwent neurotization of the axillary and the musculocutaneous nerves, the use of intraplexal nerves (motor branches of the brachial plexus) as donors of motor fibers was associated with a significantly higher success rate than the use of extraplexal nerves (81% compared with 49%, respectively, p = 0.003). Because of poor functional results of axillary nerve neurotization using extraplexal nerves (success rate 47.4%), the authors used end-to-side neurorrhaphy in 14 cases of incomplete avulsion. The success rate for end-to-side neurorrhaphy using the axillary nerve as a recipient was 64.3%, similar to that for neurotization using intraplexal nerves (68.4%) and better than that achieved using extraplexal nerves (47.4%, p = 0.19). CONCLUSIONS: End-to-side neurorrhaphy offers an advantage over classic neurotization in not requiring sacrifice of any of the surrounding nerves or the fascicles of the ulnar nerve. Typical synkinesis of muscle contraction innervated by the recipient nerve with contraction of muscles innervated by the donor was observed in patients after end-to-side neurorrhaphy.


Asunto(s)
Anastomosis Quirúrgica/métodos , Plexo Braquial/lesiones , Plexo Braquial/cirugía , Transferencia de Nervios , Nervios Espinales/trasplante , Adolescente , Adulto , Anciano , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Recuperación de la Función , Estudios Retrospectivos , Resultado del Tratamiento
2.
Acta Otolaryngol ; 127(1): 93-7, 2007 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-17364337

RESUMEN

We present the clinical, radiological and pathological features of a case of a cranial hypertrophic pachymeningitis that developed in the course of mastoiditis and petrous apex inflammation and responded to immunosuppressive therapy only. Documented by the development of clinical findings, magnetic resonance imaging, cerebrospinal fluid changes, histopathology findings, by otosurgical intervention and finally by the insertion of a ventriculo-peritoneal shunt, the case illustrates a gradual development of pachymeningitis with consequent hydrocephalus and intracranial hypertension. We consider this disease development an example of immune-induced proliferative fibrotic changes in meninges.


Asunto(s)
Enfermedades del Nervio Abducens/complicaciones , Cloranfenicol/uso terapéutico , Hidrocefalia/complicaciones , Hidrocefalia/patología , Mastoiditis/complicaciones , Meningitis/complicaciones , Meningitis/tratamiento farmacológico , Otitis Media/complicaciones , Hueso Petroso/patología , Enfermedades del Nervio Trigémino/complicaciones , Antibacterianos/uso terapéutico , Ceftriaxona/uso terapéutico , Líquido Cefalorraquídeo/inmunología , Quimioterapia Combinada , Humanos , Hipertrofia/patología , Inmunoglobulina G/líquido cefalorraquídeo , Inmunosupresores/uso terapéutico , Imagen por Resonancia Magnética , Masculino , Mastoiditis/tratamiento farmacológico , Mastoiditis/patología , Meninges/patología , Meningitis/patología , Metotrexato/uso terapéutico , Metilprednisolona/uso terapéutico , Persona de Mediana Edad , Otitis Media/cirugía , Síndrome
3.
Neuro Endocrinol Lett ; 27 Suppl 2: 116-20, 2006 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-17159794

RESUMEN

OBJECTIVES: The aim of this study was to evaluate the correlation of neuron specific enolase (NSE), protein S100B and time-profile of Glasgow Coma Score (GCS) development with metallothionein (MT) blood levels in patients with traumatic brain injury (TBI) during 10 days of hospitalization. Patients were divided into 2 groups with respect to NSE and S100B levels - with (group I) and without (group II) GCS improvement. METHODS: Serum NSE and S100B concentrations were measured by immunochemical methods; serum metallothionein concentration by electrochemical technique. Cortical biopsies were investigated immunohistochemically and by electron microscope. A cDNA microarray containing 700 gene probes was used to study the changes in gene expression in the ipsilateral cortex. RESULTS: Values of MT in the blood of group I showed a non-significant decrease compared to group II during 1-3 days after admission. There was an increase of MT during 4-8 days in comparison with values of 1-3 days. The highest value of MT during hospitalization was found in a patient with diffuse axonal injury (group II). The data of cDNA microarray suggested an increase in expression of gene transcripts for oxygen free radical scavenger proteins corresponding with the increase of MT during 4-8 days in both groups. CONCLUSIONS: The experimental data indicate that monitoring the content of MT in patients with trauma brain injury would be a suitable approach to evaluate the degree of injury or duration of prolonging unconsciousness, particularly in diagnosis of diffuse axonal injury.


Asunto(s)
Lesiones Encefálicas/sangre , Metalotioneína/sangre , Factores de Crecimiento Nervioso/sangre , Fosfopiruvato Hidratasa/sangre , Proteínas S100/sangre , Lesiones Encefálicas/diagnóstico por imagen , Lesiones Encefálicas/metabolismo , Perfilación de la Expresión Génica , Humanos , Imagen por Resonancia Magnética , Factores de Crecimiento Nervioso/metabolismo , Fosfopiruvato Hidratasa/metabolismo , Radiografía , Subunidad beta de la Proteína de Unión al Calcio S100 , Proteínas S100/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA